Literature DB >> 25701078

Quality of life in psychosis: prevalence and associated factors in a Nigerian clinical population.

V O Lasebikan1, E T Owoaje.   

Abstract

Aim of the study was to assess sociodemographic and clinical determinants of quality of life in psychotic patients in a general hospital population in Nigeria. Information was obtained on demography, duration of untreated illness (DUI) and functioning among Schizophrenia (368), schizoaffective disorder (70), and 214 patients with affective psychosis. Functioning was assessed using GAF, severity of psychopathology with PANSS and quality of life using WHOQoL-BREF. In general, the differences in the QoL across the three psychotic disorders were small. Linear regression analysis, showed that high GAF p < 0.001, medication adherence, p = 0.007 were associated with good QoL in schizophrenia, low PANSS p < 0.001 and short DUI p = 0.001 in schizoaffective disorder and low PANSS, high GAF p < 0.001 respectively in affective psychosis. QoL and its determinants in psychosis are not absolutely different. More research is required in this area.

Entities:  

Mesh:

Year:  2015        PMID: 25701078     DOI: 10.1007/s10597-015-9842-z

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  25 in total

Review 1.  Revising axis V for DSM-IV: a review of measures of social functioning.

Authors:  H H Goldman; A E Skodol; T R Lave
Journal:  Am J Psychiatry       Date:  1992-09       Impact factor: 18.112

2.  Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders.

Authors:  Samuli I Saarni; Satu Viertiö; Jonna Perälä; Seppo Koskinen; Jouko Lönnqvist; Jaana Suvisaari
Journal:  Br J Psychiatry       Date:  2010-11       Impact factor: 9.319

3.  The family history method using diagnostic criteria. Reliability and validity.

Authors:  N C Andreasen; J Endicott; R L Spitzer; G Winokur
Journal:  Arch Gen Psychiatry       Date:  1977-10

4.  The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance.

Authors:  J Endicott; R L Spitzer; J L Fleiss; J Cohen
Journal:  Arch Gen Psychiatry       Date:  1976-06

5.  A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics.

Authors:  M M Singh; S R Kay
Journal:  Psychopharmacologia       Date:  1975-08-21

6.  [Bipolar disorder and quality of life: A cross-sectional study including 104 Tunisian patients].

Authors:  I Marrag; K Hajji; M Hadj Ammar; L Zarrouk; R Kachouri; M Nasr
Journal:  Encephale       Date:  2014-09-18       Impact factor: 1.291

7.  Course of adolescent psychotic disorder with schizoaffective episodes.

Authors:  B Lay; M H Schmidt; B Blanz
Journal:  Eur Child Adolesc Psychiatry       Date:  1997-03       Impact factor: 4.785

8.  Improved quality of life over one year is associated with improved adherence in patients with schizophrenia.

Authors:  K P Hayhurst; R J Drake; J A Massie; G Dunn; T R E Barnes; P B Jones; S W Lewis
Journal:  Eur Psychiatry       Date:  2013-06-12       Impact factor: 5.361

Review 9.  Biomarkers of bipolar disorder: specific or shared with schizophrenia?

Authors:  Frank Bellivier; Pierre Alexis Geoffroy; Jan Scott; Franck Schurhoff; Marion Leboyer; Bruno Etain
Journal:  Front Biosci (Elite Ed)       Date:  2013-06-01

10.  Schizophrenia: Impact on quality of life.

Authors:  Ram Kumar Solanki; Paramjeet Singh; Aarti Midha; Karan Chugh
Journal:  Indian J Psychiatry       Date:  2008-07       Impact factor: 1.759

View more
  3 in total

1.  Relationship between quality of life and social integration among patients with schizophrenia attending a Nigerian tertiary hospital.

Authors:  Temitope Ogundare; Peter O Onifade; 'Deji Ogundapo; Senait Ghebrehiwet; Christina P C Borba; David C Henderson
Journal:  Qual Life Res       Date:  2021-02-01       Impact factor: 4.147

2.  Systematic review of global functioning and quality of life in people with psychotic disorders.

Authors:  A G Nevarez-Flores; K Sanderson; M Breslin; V J Carr; V A Morgan; A L Neil
Journal:  Epidemiol Psychiatr Sci       Date:  2018-10-01       Impact factor: 6.892

3.  Telemedical care and quality of life in patients with schizophrenia and bipolar disorder: results of a randomized controlled trial.

Authors:  Ulrike Stentzel; Neeltje van den Berg; Kilson Moon; Lara N Schulze; Josephine Schulte; Jens M Langosch; Wolfgang Hoffmann; Hans J Grabe
Journal:  BMC Psychiatry       Date:  2021-06-29       Impact factor: 3.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.